FlunarizineThird Party Manufacturing in India

Flunarizine works by blocking calcium ions from entering cells through voltage-gated calcium channels, particularly in vascular smooth muscle and neuronal tissues. This selective calcium entry blockade prevents excessive calcium influx that would otherwise trigger vasoconstriction and neuronal hyperexcitability. By stabilising cell membranes and reducing intracellular calcium accumulation, flunarizine protects neurons from hypoxic damage and prevents the release of pro-inflammatory mediators. The drug also exhibits calmodulin binding properties, which further modulates calcium-dependent cellular processes. Unlike other calcium channel blockers that primarily act on peripheral vasculature, flunarizine crosses the blood-brain barrier readily, allowing it to exert its therapeutic effects directly on cerebral blood vessels and vestibular pathways. This central activity makes it particularly effective for migraine prophylaxis and vertigo management. The drug additionally demonstrates histamine H1 receptor blocking activity, which contributes to its antivertigo effects. Flunarizine does not significantly affect heart rate or blood pressure at therapeutic doses, distinguishing it from dihydropyridine calcium channel blockers. Its long half-life allows for once-daily dosing, and therapeutic benefits typically become apparent after several weeks of continuous treatment.

Therapeutic Uses

Flunarizine is prescribed for the following conditions:

• Migraine Prophylaxis: Flunarizine is widely used for the preventive treatment of migraine headaches. It reduces the frequency, severity, and duration of migraine attacks in both adults and children, particularly in patients with frequent or disabling episodes.

• Vertigo of Central and Peripheral Origin: Flunarizine is highly effective for managing vertigo associated with vestibular disorders, including benign paroxysmal positional vertigo, Meniere's disease, and vestibular neuritis. Its antivertigo effect stems from both its calcium channel blocking and antihistaminic properties.

• Peripheral Vascular Disease: Flunarizine is used as adjuvant therapy in occlusive peripheral vascular disease, including intermittent claudication and Raynaud's phenomenon, where it improves microcirculation by reducing vasospasm.

• Epilepsy: As an adjuvant in the therapy of epilepsy, flunarizine may reduce seizure frequency in patients with refractory epilepsy, particularly those with partial seizures.

Why Manufacturers Choose Flunarizine

Flunarizine is a well-established molecule with consistent demand in both domestic and export markets. Its multiple therapeutic applications across neurology and vascular medicine create diversified demand from PCD franchise operators and institutional buyers. Indian manufacturers benefit from the relatively straightforward synthesis process and the availability of pharmaceutical-grade raw materials from domestic API producers. The molecule is commonly manufactured as 5mg and 10mg tablets, making it a staple product for third party manufacturing units targeting the neurology segment. With increasing prevalence of migraine and vestibular disorders globally, flunarizine continues to be one of the most sought-after molecules for contract manufacturing in India, with steady demand from WHO-GMP certified facilities producing for regulated markets.